RecensMedical, Inc. · 임원ㆍ주요주주특정증권등소유상황보고서
Report on Specified Securities Owned by Officers and Major Shareholders
6.1
주식회사 리센스메디컬
20261102
Report on Specified Securities Owned by Officers and Major Shareholders
| To: Securities and Futures Commission | ||
| To: Korea Exchange | ||
| Reporting obligation date: | 2026-11-02 | |
| Report reference date: | 2026-11-09 | |
| ※ The reporting person confirms that ownership of specified securities as of the reference date is accurately stated per applicable laws and filing instructions, with no material misstatement or omission. |
| Reporting person: | 김건호 |
| Company Name | 주식회사 리센스메디컬 | ||
| Entity type | KOSDAQ-Listed Company | Company code | 394420 |
| Total Shares Issued | 10,999,701 | ||
| Report Type | Change | Reporting person type | Individual (Domestic) | |
| Name (Entity Name) | Korean | 김건호 | Chinese characters (English) | 金建浩(Gun-Ho Kim) |
| Date of Birth or Business Registration No., etc. | 800723 | |||
| Address (Head Office) [Town/District Level Only] | 경기도 화성시 동탄구 | |||
| Relationship to Issuer | Officer (Registered or Not) | Registered Officer | Position | Co-CEO |
| Appointment Date | 2025.10.18 | Resignation Date | - | |
| Major Shareholder | De facto controlling shareholder | |||
| Business contact and person in charge | Affiliated company | 주식회사 리센스메디컬 | Department | IR공시팀 |
| Position | Assistant Manager | Phone Number | 031-80*** | |
| Name | 소하영 | Fax number | 031-63** | |
| Email address | **recensmedical.com | |||
| Report reference date | Specified Securities | Share Certificates | |||
| Number of Specified Securities (shares) | Ratio (%) | Number of Shares (shares) | Ratio (%) | ||
| Previous Report | 2026.04.07 | 2,170,059 | 20.00 | 2,170,059 | 20.00 |
| This Report | 2026.11.09 | 2,190,059 | 19.91 | 2,190,059 | 19.91 |
| Change | 20,000 | -0.09 | 20,000 | -0.09 | |
주) 실제 보유주식등의 수는 장내매수로 증가하였으나, 보고기간 내 주식매수선택권 행사 등의 사유로 전체 주식 수가 늘어나 보유 비율이 감소하였습니다.
| Details of Specified Securities | |||||||||
| Share certificates | Instruments representing preemptive rights | Convertible bonds | Bonds with warrants | Participating Bonds | Exchangeable bonds | Depositary receipts | Other | Total | |
| Number of shares | Ratio (%) | ||||||||
| 2,190,059 | - | - | - | - | - | - | - | 2,190,059 | 19.91 |
| A | B | C | D | E | F | G | H | ||
| I | |||||||||
| Total Shares Issued (J) | Number of Specified Securities Other Than Shares (B+C+D+E+F+G+H=I) | Ownership ratio (%) | |
| Ownership Ratio of Specified Securities [A+I / J+I-(F+G+H)※] × 100 | Shareholding Ratio (A / J) × 100 | ||
| 10,999,701 | - | 19.91 | 19.91 |
※ Ownership ratio excludes from the denominator only exchangeable bonds exchangeable into shares and depositary receipts, derivative-linked securities, etc. with shares as underlying
| Reason for Report | Change Date* | Type of Specified Securities | Shares Owned (shares) | Acquisition/Disposal Unit Price (KRW)** | Remarks | Trading plan report date | ||
| Before Change | Change | After Change | ||||||
| On-Market Purchase (+) | 2026.11.02 | Common Stock | 2,170,059 | 4,000 | 2,174,059 | 5,023 | - | - |
| On-Market Purchase (+) | 2026.11.03 | Common Stock | 2,174,059 | 3,950 | 2,178,009 | 5,155 | - | - |
| On-Market Purchase (+) | 2026.11.04 | Common Stock | 2,178,009 | 4,070 | 2,182,079 | 5,117 | - | - |
| On-Market Purchase (+) | 2026.11.05 | Common Stock | 2,182,079 | 2,980 | 2,185,059 | 5,426 | - | - |
| On-Market Purchase (+) | 2026.11.06 | Common Stock | 2,185,059 | 5,000 | 2,190,059 | 4,897 | - | - |
| Total | 2,170,059 | 20,000 | 2,190,059 | 5,097 | - | |||
* For trades on the securities market, the settlement date
** For securities other than shares, the exercise (conversion/exchange) price of the securities or the unit price of shares acquired/disposed of through exercise of rights; amounts in ( ) are the unit price of the securities